Tech Company Financing Transactions
Inception 4 Funding Round
On 12/13/2013, Inception 4 raised $10 million in Series A funding from Versant Ventures.
Transaction Overview
Company Name
Announced On
12/13/2013
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Versant Ventures (Brad Bolzon)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6175 Nancy Ridge Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeremy Caldwell
Chief Operating Officer
Scott Forrest
Chief Scientific Officer
Richard Glynne
Vice President
Bryan Laffitte
Browse more venture capital transactions:
Prev: 12/13/2013: QuickPay venture capital transaction
Next: 12/13/2013: Allegiance venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs